HUDDINGE, Sweden, Nov. 3, 2017 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announces today that it has appointedErik Björk as Chief Financial Officer effective January 3, 2018.
Erik Björk will join Medivir from AstraZeneca where he has been the CFO for Sweden Operations. He has extensive experience as a global financial leader
"I am delighted to welcome Erik to Medivir. He brings a combination of industry experience in strong operating companies and specialized investment and financial reporting skills and we look forward to his contributions in supporting Medivir's growth," says Christine Lind, CEO at Medivir.
Erik will be a member of the Medivir Executive Team and report to Christine Lind, CEO. His responsibilities will include leading the operational activities of the Finance & Administration function and Investor Relations.
"Medivir's mission to bring transformative drugs to patients gives it a clear purpose, strong values and a positive culture. I am excited to become part of a company that has already achieved so much, that has a strong development pipeline, and to assist in realizing the company's potential," says Erik Björk.
For further information, please contact: Christine Lind CEO Medivir AB Phone: +46-(0)-8-407 46 41
Medivir AB is obliged to make this information public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08.30 CET on 3 November 2017.
About Medivir Medivir is a research-based pharmaceutical company with a focus on oncology. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical needs. Medivir is listed on the Nasdaq Stockholm Mid Cap List.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Press release (PDF): http://mb.cision.com/Main/652/2382291/745965.pdf
View original content:http://www.prnewswire.com/news-releases/medivir-appoints-erik-bjork-as-chief-financial-officer-300549171.html
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All